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Access tunnelCytochrome P450 (CYP) 17A1 is a dual-function monooxygenase with a critical role in the synthesis of many
human steroid hormones. The enzyme is an important target for treatment of breast and prostate cancers that
proliferate in response to estrogens and androgens. Despite the crystallographic structures available for
CYP17A1, nomembrane-bound structural features of this enzyme at atomic level are available. Accumulating ev-
idence has indicated that the interactions between bounded CYPs andmembrane could contribute to the recruit-
ment of lipophilic substrates. To this end, we have investigated the effects on structural characteristics in the
presence of themembrane for CYP17A1. TheMD simulation results demonstrate a spontaneous insertion process
of the enzyme to the lipid. Two predominantmodes of CYP17A1 in themembrane are captured, characterized by
the depths of insertion and orientations of the enzyme to the membrane surface. The measured heme tilt angles
show good consistencewith experimental data, thereby verifying the validity of the structuralmodels. Moreover,
conformational changes induced by the membrane might have impact on the accessibility of the active site to
lipophilic substrates. The dynamics of internal aromatic gate formed by Trp220 and Phe224 are suggested to
regulate tunnel openingmotions. The knowledge of themembrane binding characteristics could guide future ex-
perimental and computational works on membrane-bound CYPs so that various investigations of CYPs in their
natural, lipid environment rather than in artiﬁcially solubilized forms may be achieved.
© 2015 Published by Elsevier B.V.1. Introduction
The CYPs are ubiquitous heme-containing mixed function
oxygenases that catalyze the hydroxylation of non-activated hydrocar-
bon reactions, dealkylation, epoxidation, and dehydrogenation
reactions involved in the oxidative metabolism [1–5]. They play an
important role in the metabolism of endogenous and exogenous sub-
strates like drugs and environmental chemicals [6,7]. The active site of
CYPs is usually isolated from the surrounding solvent, and the heme
cofactor is buried in the core of the enzymes [8]. Thus, the question of
how reactants enter or exit the active site of the enzyme has become
particularly important for membrane-associated CYPs.dynamics; TM, transmembrane;
, particle mesh Ewald; PO4,
earch Laboratory ofNano-micro
l and Computational Chemistry,
hun 130023, PR China.CYPs are anchored in the membrane by an N-terminal TM α helix
[9–14]. The heme tilt angle with respect to the membrane (the dihe-
dral angle between the heme plane and the membrane plane) has
been estimated experimentally to be between 38° and 78° for differ-
ent CYP isoforms [15]. Recently, several groups have focused on the
structural dynamics of the membrane-bound CYPs [10,16–23].
They used highly mobile membrane mimetic model/coarse grained
simulations to observe the binding and insertion of CYPs, or initially
immersed CYPs into the membrane to investigate the structural
characteristics of the membrane-bound CYP isoforms. Accumulating
evidence has discovered that the orientations may differ between indi-
vidual CYPs, and some isoforms may even adopt different orientations
in the membrane [10,11,15–24]. However, if different CYPs actually
adopt different orientations in the membrane, the provided insightful
information about the dynamics of the membrane-bound CYPs might
be limited for other investigated isoforms, such as CYP17A1, an impor-
tant target for the treatment of breast and prostate cancers.
CYP17A1 (also known as cytochrome P450c17) is a membrane-
bound dual-function monooxygenase with a vital role in both adrenal
and gonadal steroidogenesis in mammals [25,26]. As a key enzyme in
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ities of CYP17A1 are required for the biosynthesis of androgenic ste-
roids and estrogens in the adrenal zona reticularis and in gonads
[27–29]. Given the fact that large number of lipophilic substrates
metabolized by CYP17A1 primarily partition in the membrane, a
daunting challenge is to provide the high-resolution structural de-
termination of the membrane-associated state of CYP17A1. To this
end, we have performed the full-atomistic MD simulations with
lipid bilayer to study the binding and interaction of CYP17A1 to the
membrane. The aims of this work are to answer the following ques-
tions: (i) what are the insertion depths and orientations of CYP17A1
on the membrane?, (ii) what are the key residues that may control
the speciﬁc orientations of the globular domain of CYP17A1 to the
membrane?, and (iii) what is the inﬂuence of the lipophilic environ-
ment of themembrane on the accessibility of the possible access tun-
nels?Withmultiple independent simulations, spontaneous insertion
of the globular domain to the membrane has been captured,
resulting in convergent models for the membrane-bound form of
CYP17A1. The insertion orientations on the membrane show well
agreement with the available experimental data [15]. Meanwhile,
by using the full-atomistic MD simulations, a dynamic interacting
procedure of the globular domain of CYP17A1 with the membrane
was captured, which was not taken into account in previous simula-
tions with simpliﬁed model of the lipid bilayer. These detailed
membrane-induced hydrogen-bonding and hydrophobic interac-
tions are inferred to anchor the protein within the membrane envi-
ronment and to be closely relevant to control the pose of CYP17A1
on the membrane. Furthermore, the results suggest that the dynam-
ics of aromatic residues may regulate the tunnel opening motions.
The opening of tunnel 2fg was facilitated by the opening of the inter-
nal aromatic gate formed by Trp220 and Phe224. Together, the struc-
tural models resulting from the simulations allow for a detailed
description of the structure–function relationships of CYP17A1
membrane-bound form, and could contribute to further understand-
ing about the CYP17A1 associated polycystic ovary disease.2. Computational methods
2.1. Preparation of the structure
Initial structure for CYP17A1 in complex with abirateronewas taken
from Protein Data Bank (PDB ID: 3RUK). Structures for the N-terminal
TM helix (Δ1–19 residues) and part of the Pro-rich loop (Δ20–30 resi-
dues), which are missing in the crystal structure, were modeled using
Discovery Studio 3.0 [30]. Crystallographic water molecules were
maintained. Abiraterone was removed from the prepared structure
to obtain the substrate-free form of CYP17A1 for the subsequent
docking study. The initial model of progesterone was obtained
from DrugBank (http://www.drugbank.ca/; accession number:
DB00396). CDOCKER protocol of Discovery Studio 3.0 [30] was used
to create the docked CYP17A1–progesterone complex structure.
Default settings for protein-small molecule docking were used. It is
widely known that the heme group in iron(ΙV)–oxo heme(+·), or
CpdΙ was considered to be the main reactive species of the CYP cata-
lytic cycle [31–33]. Thus, in the present study, the active species of
CYP17A1 was determined as iron–oxo-porphine complex, and the
heme iron was ligated by the side chain thiolate group of the con-
served cysteine residue (Cys442). The force ﬁeld parameters of
CpdΙ were obtained from previous QM/MM simulations reported by
Cheatham et al. [34]. The structural optimization of progesterone
was conducted using B3LYP combined with 6–31+G* basis set
using the Gaussian 09 software [35]. RESP ﬁtting procedure was
used for charge derivation based on the optimal conformation. Final-
ly, the force ﬁeld parameters of progesterone were derived using the
antechamber module of AMBER 11 [36].2.2. MD simulations
For membrane-bound simulated systems, an explicit POPC bilayer
[37] was used as a template to mimic the membrane environment
because it is one of the major components of endoplasmic reticulum
membrane (N50% phosphatidylcholine [38,39]). The TM helix was
initially immersed into the POPC bilayer. The globular domain of
CYP17A1–progesterone complex was placed in ﬁve different initial ori-
entations, between 6 and 9 Å above the surface of the membrane. The
initial orientations were obtained by ﬁrst aligning the three principal
axes of the protein to the xyz axes, respectively, and then rotating the
principal axis aligned to z in different planes. In the present study, we
obtained ﬁve different initial heme tilt angles. For comparison,
CYP17A1 was also simulated in an aqueous solution. The systems
were solvated with TIP3P water molecules and neutralized by chloride
ions (Cl−). All the atoms in the systems were described with AMBER
[36,40] ff99SB force ﬁeld [41]. GROMACS v4.6.5 [42] was used to run
the simulations. Long range electrostatics were calculated using the
PME method [43,44] with a 12 Å cut-off. Van der Waal interactions
were modeled using Lennard–Jones 6–12 potentials with a 14 Å cut-
off. All the simulations were conducted at a constant temperature of
300 K using the Berendsen thermostat. All bonds involving hydrogen
atoms were constrained by the use of the SHAKE algorithm [45,46].
The time step in all MD simulations was set to 2 fs. Prior to production
runs, energy minimization of 3000 steps of the steepest descent was
carried out on each system followed by 5000 steps of conjugate gradient
minimization. Subsequently, the minimized systemswere heated grad-
ually from 0 K to 300 K, and then equilibrated for a 1 ns NPT process. A
100 ns production run was conducted on each system, two of which
were continued to 150 ns for further study.
The cluster analysis was performed using the average linkage as the
clustering algorithm and backbone atom RMSD as the distance metric.
The chosen of the representative structures can be summarized as
follows: under the average linkage algorithm, the distance from
one cluster to another is deﬁned as the average of all distances be-
tween individual points of the two clusters. At each iteration step,
the two closest clusters are merged. This merging continues until
the desired number of clusters is obtained (here is 5). The represen-
tative structures of the clusters with the highest occurrences were
chosen to present the structural information. All of the ﬁgures were
created with Chimera [47].2.3. New analysis of access tunnels
The access tunnels from the surface to the active site are very impor-
tant for understanding the function of an enzyme [48]. In the present
study, the transport pathways of CYP17A1 had been characterized by
CAVER 3.0 [49,50]. Caver is a widely used software tool for automatic
analyzing large ensembles of protein conformations [51–53]. The
progesterone above the heme group was chosen as the starting
point for tunnel searching. To investigate the opening of tunnels
during the spontaneous binding and insertion of CYP17A1 into the
membrane, 200 snapshots of each MD simulation trajectory were
extracted at an interval of 500 ps. If the minimum radius of the seg-
ments along a tunnel was greater than 1.2 Å at least on snapshot of
the simulations, the tunnel was collected. This value was chosen to
be slightly lower than the usual probe radius of water of 1.5 Å
because the radii calculated with the program are smaller than the
actual radii of the tunnels. Then the identiﬁed tunnels of the last
50 ns MD simulations were characterized by the average-link algo-
rithm based on the pairwise distances of the tunnels. The probe radi-
us and the clustering threshold were set to 1.2 and 3.5, respectively.
Default settings for other parameters were used throughout the
calculations. The maximum number of tunnel clusters was set to
999. Then the tunnels were visualized using Chimera [47].
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3.1. Preparation for identifying the CYP17A1–progesterone complex
structure
DeVore and Scott [25] determined the crystallographic structure of
CYP17A1 with an inhibitor abiraterone to elucidate the structural
features of this enzyme in 2012 (Fig. S1). However, no experimental
crystallographic structures of CYP17A1–substrate complex are available
in the course of our study. Thus, progesterone, which is the native
CYP17A1 substrate, has been docked into the CYP17A1 substrate-free
form to investigate the access of lipophilic substrate to the active site
through the membrane. The metabolism of progesterone via CYP17A1
is essential for the biosynthesis of glucocorticoids and sex steroid pre-
cursors [54]. CYP17A1 can mediate 17-hydroxylation of progesterone
to generate 17-OH progesterone, which can further be converted to
glucocorticoids. After 17-hydroxylation, CYP17A1 also mediates the
cleavage of the C17–C20 bond of 17-OH progesterone to form andro-
stenedione, which is an important precursor for the production of estro-
gens and androgens [55]. Initial structure for CYP17A1 in complex with
abiraterone was taken from Protein Data Bank (PDB ID: 3RUK) [25].
After docking, the conformation with the highest score among the cap-
tured complex conformations was chosen. Recently, Scott et al. [56]
have also determined CYP17A1 mutant A105L with several substrates,
including progesterone. Similar orientation and binding mode of the
docked model of CYP17A1–progesterone complex were acquired com-
pared to the newly crystallized structure proposed by Scott et al. [56]
in their recent research (Fig. S2). The A ring of progesterone packs ﬂat
against the I helix and extends between the F and G helices. The
distances between the protons of C17 and C16 atoms and the catalytic
oxygen atom of CpdІ were measured as about 2.65 Å (standard devia-
tion: 0.21 Å) and 3.10 Å (0.37 Å) correspondingly throughout the last
50 ns simulations. The measured distances are consistent with the ex-
perimentally observedmajor 17α-OH andminor 16α-OH progesterone
metabolites [25].
3.2. Spontaneous binding of the globular domain to the membrane and the
orientations of the membrane-bound CYP17A1
After acquiring the complex structure of CYP17A1with the lipophilic
substrate, the TM helix of the enzyme was initially immersed into the
POPC bilayer, whereas the globular domain was placed above the lipidFig. 1. Spontaneous binding and insertion of CYP17A1 into the membrane at different time po
bound form of CYP17A1, highlighting the regions having close contact with the membrane. Th
and β11′–β12′ sheets are shown in ribbon representation in purple, yellow, and blue, respectibilayer at different orientations for ﬁve parallel MD simulations
(Mem1 to Mem5). In the present study, the explicit POPC bilayer was
used as a template to mimic the membrane environment because it is
one of the major components of endoplasmic reticulum membrane
(N50% phosphatidylcholine [38,39]). In the 100 ns simulations, sponta-
neous binding and immersion process of the globular domain to the
membrane were consistently observed in all ﬁve simulations (Figs. 1
and S3).
The binding of the globular domain of CYP17A1 to the membrane
was observed during the ﬁrst 20 ns of the simulations independent of
the globular domain's initial orientation. After membrane attachment,
the globular domain of the enzyme oriented itself to a favorable position
and penetrated into themembrane during approximately 20 to 50 ns of
theMD simulations. Then, the orientation and the penetration depth for
each simulated system did not signiﬁcantly change over the remainder
of the 100 nsMD simulations. Moreover, the TM helix displayed a small
precessionmovement around themembrane normal inside the lipid bi-
layer. Finally, two distinct possible orientations were obtained from the
MD simulations. From our simulations, the orientation of CYP17A1 after
the associationwith themembranewas characterized bymeasuring the
heme tilt angle with respect to the membrane normal (z-axis).
The initial and obtained average tilt angles for each simulated sys-
tem are listed in Table 1. Time evolutions of the heme tilt angles for all
simulated membrane systems (Mem1 to Mem5) are presented in
Fig. 2. As shown in Fig. 2, all tilt angles rapidly changed during the ﬁrst
50 ns. For the remainder of the simulations, the values averaged ~40°
for Mem1 and Mem3, whereas they extended to much larger values
between 58° and 65° for Mem2, Mem4, and Mem5, with an overall
average of ~60°. In order to characterize the convergences of the distinct
tilt angels, two of the simulations (Mem1 andMem5)were extended to
150 ns. The results demonstrated that no large-scale tilting ﬂuctuations
between 40° and 60° were observed during the extended 50 ns of the
simulations, indicating that two stable conﬁgurations were obtained
from theMDsimulations. Remarkably, the obtained two possible tilt an-
gles are consistent with the experimental values as 47° or 63°[15],
thereby verifying the validity of the structural models. In addition,
such non-unique tilt angles of CYP17A1 are also observed in other CYP
isoforms, such as P450c21, which has tilt angles as 38° or 78° [15].
Although two possible tilt angles were obtained for CYP17A1, the con-
vergences of the two predominant orientations still suggest the speciﬁc
orientations of CYP17A1 binding to the membrane, rather than a non-
speciﬁc adsorption to the membrane surface.ints for the ~40° tilt angles membrane-bound systems. Close-up view of the membrane-
e CpdI and progesterone are shown in blue stick representation. The F–G helices, A helix,
vely.
Table 1
Initial and average heme tilt angles calculated for all the simulated membrane-bound
systems.
System Initial tilt angle (degree) Average tilt angel (degree)
Mem1 17.42 41.35 ± 3.28
Mem2 36.87 58.29 ± 3.29
Mem3 54.57 40.98 ± 3.54
Mem4 61.52 65.71 ± 3.70
Mem5 81.75 64.85 ± 3.55
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the associated conformational changes
Fig. 3 summarizes the heights of the center of mass of the predomi-
nant anchorage regions in the globular domain of CYP17A1. Inspection
of the trajectories revealed the penetration of the anchorage regions
into the membrane before the formation of the enzyme–membrane
complex. In general, the initial insertion began with the F–G loop,
followed by the A helix and β11′–β12′ sheets in all simulated systems.
More speciﬁcally, for the simulated systems with ~60° tilt angles, the
penetration of the F and G helices occurred after the binding of the
F–G loop, and these regions are proposed to be the primary attachment
point for the globular domain of CYP17A1 to the membrane. Previous
experimental study [15] has demonstrated that a considerable part of
CYP17A1 is deeply embedded into the lipid bilayer. Larger tilt angle is
inferred to penetrate more surface of the helix F–G region with its
hydrophobic tip immersing deeper into the membrane. In the present
study, the depths of insertion of the globular domain in the membrane
were approximately 20–23 Å for simulations with ~60° tilt angles and
9–11 Å for ~40° tilt angle systems (Fig. S4A, B). As shown in Fig. S4,
the globular domain of CYP17A1 was more inclined toward the mem-
brane for the simulations with ~60° tilt angles. Consequently, the loca-
tions of β1 sheets (β11′, β12′, β13′, and β14′) relative to the
membrane surface were slightly different, especially for β11′–β12′
sheets that were immersed below the lipid headgroups. In addition,
β31′, β32′–β33′, and β41′–β42′ sheets were more immersed for the
simulations with ~60° tilt angles as they made closer contact with the
lipid bilayer. Although the regions including D, E, I, J, and K helices
remained above the membrane, they located much closer to the mem-
brane in ~60° tilt angle systems. However, the D–E loop and β3 sheets
had no contact with the membrane for ~40° tilt angle systems. The F
andG helices were observed to insert deeply into themembrane hydro-
phobic interior for the simulations with ~60° tilt angles, but to a lesser
extent for ~40° tilt angle systems.Fig. 2. Orientations of CYP17A1 upon binding to the membrane: time evolution of the
heme tilt angle for the membrane-bound systems. The angle θ is deﬁned as the angle be-
tween the membrane normal (z-axis) and the heme plane.Fig. S5 shows the number of contacts between the protein residues
and the lipids. Aliphatic residues (L, I and V) and aromatic residues
(F, Y and W) preferred to penetrate deep into the membrane and con-
tact with lipid tails, whereas charged (R, K, D and E) and polar residues
(S, T, N andQ)mainlymade contactswith the headgroup region.Hydro-
phobic and charged residues in contactwith the lipids are demonstrated
in Fig. S6. For the simulations with ~60° tilt angles, the globular domain
of CYP17A1 exhibited larger contact surface with the lipids. The princi-
pal difference occurred on the helix F–G region, B–C loop, and the loop
between β3 and β4 sheets, especially for the F–G region.
Signiﬁcant local conformational changes at the membrane interface
accompany the process of the protein insertion into the membrane.
Fig. 4 demonstrates the membrane-induced conformational changes
of the F–G helices hydrophobic tip, and the corresponding rearrange-
ment of the key hydrophobic residues which interact with the lipid bi-
layer. For comparison, CYP17A1 was also simulated in an aqueous
solution. The representative structures for the membrane-bound and
solution form of CYP17A1 were superimposed with each other based
on the Cα atoms of the globular domain of CYP17A1. As shown in
Fig. 4, the conformational changes of the local structuralmotifs are com-
pared to those in the solution simulation. With the immersion of the
globular domain of CYP17A1, the F–G loop with its hydrophobic core
composed of residues Leu214, Val215, Leu217, Val218, Trp220,
Leu221, Ile223, and Phe224 inserted deeper into themembrane and ex-
tended away from the B–C loop. Other basic residues (Lys211, Lys227,
Lys231, and Lys237) and polar residue Asn226 mainly interacted with
the lipid headgroups. Concomitant movement of the G helix appeared
to be associated with the extended conformational change of the F–G
loop.
However, binding of CYP17A1 to themembrane does not induce any
global conformational changes in the enzyme within the simulated
time, as measured by the backbone RMSD with respect to their initial
coordinates, which shows values b3.0 Å (Fig. S7). Another look at the
plots in Fig. S8 points out the structural stability of the individual ele-
ments of secondary structure. As shown in Fig. S8, on average, the global
secondary structures are well maintained over the 100 ns simulations.
On the basis of the above structural analysis, the global protein structure
and the overall topology for CYP17A1 are quite reserved upon binding
to the membrane. Local conformational changes, which are mostly
located at themembrane–protein interface, likely arise due to the inter-
action of CYP17A1 with the membrane, and may further impact on the
opening and closing of different tunnels for efﬁcient recruitment of the
lipophilic substrates from the membrane to the enzyme's buried active
site.
3.4. The details of insertion: membrane-induced interactions of the enzyme
with lipid molecules
To further characterize the detailed interactions between CYP17A1
andmembrane, we analyzed the hydrogen bonds, as well as the hydro-
phobic interactions formed between the residues and the lipid mole-
cules in the membrane, in particular for the anchorage regions which
penetrated into the lipid bilayer. In general, the predominant
hydrogen-bonding interactions with the lipid molecules were either
via basic residues (Lys and Arg) and polar residues (Ser, Thr, Gln, and
Asn), or via the backbones of the hydrophobic residues (especially Leu
and Phe) to a lesser extent. More speciﬁcally, Mem1 and Mem5 were
taken as the representative systems of the two distinct orientations to
demonstrate the detailed contacts of the protein with the membrane
(Table S1). Time evolutions of the hydrogen bond occupancies are
shown in Figs. 5 and S9. As shown in the hydrogen-bonding ﬁgures,
residues Arg20, Arg21, and Lys26 were located in the Pro-rich loop
and formed continuous hydrogen bonds with lipid bilayer during the
simulation. These hydrogen bonds were relatively stable throughout
the entire trajectory. Different from these fairly constant hydrogen
bonds, some individual terms varied with their positions. With the
Fig. 3. Time series of the height of the center of mass of the A helix, β11′–β12′ sheets, and F–G helices in all ﬁvemembrane simulations. The average positions of the PO4 group of the lipid
headgroups are also shown.
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the lipid headgroups and the residues located in speciﬁc regions were
established, including the Pro-rich loop (Ser33, Leu34, Ser39, Leu40,
Phe42, Leu43, and Arg45), B–C loop (Arg67 and Thr70), F–G loop
(Lys211 and Lys231), and the loop between the β32′–β33′ sheets
(Gln472 and Ser475). These hydrogen-bonding interactions remained
bounded after 50 ns of the simulation.
Remarkably, the tilt angle was ~40° when Asn108, Arg109, Ser164,
Lys237, and Lys490 were unable to form hydrogen bonds with the
lipid headgroups, but it turned to be ~60° when these interactions
were formed. In addition, lysine residue is known to bind either near
the lipid tail or the headgroup interface, as it can create both favorable
hydrogen bonds and hydrophobic interactions. In the present study,
Asn226 and Lys227, which are located in the F–G loop, initially made
contacts with the lipid headgroups by inserting the extended F–G loopFig. 4.Membrane-induced conformational changes of the hydrophobic tip of the helix F–G re
CYP17A1 in the membrane-bound form and in the solution form is shown in ribbon represent
is shown in purple ribbon representation. Hydrophobic residues are shown in stick representainto the lipid bilayer from solvent. However, when the tilt angle was
~60°, these two residues gradually lost the contact with the lipid
headgroups as the globular domain inserted deeper into themembrane
hydrophobic interior, and occasionally contacted the hydrophilic
headgroups on the other side of the membrane. Then, new hydrogen
bonds were intermittently formed.
In addition to the electrostatic interactions, the globular domain of
CYP17A1 encountered the membrane mainly through the hydrophobic
anchor of the F–G loop composed of Leu214, Val215, Leu217, Val218,
Trp220, Leu221, Ile223, and Phe224 (Fig. 4). These nonpolar and aro-
matic residues formed predominantly hydrophobic interactions with
the membrane lipid tails, contributing to the stability of CYP17A1 with
the membrane. Other hydrophobic residues located in the anchorage
regions (the Pro-rich loop, A helix, β1 and β3 sheets) could also partic-
ipate in the hydrophobic contacts with themembrane to a lesser extent.gion for the membrane-bound systems with (A) ~40° tilt angles and (B) ~60° tilt angles.
ation in green and dark yellow, representatively. F–G loop in the membrane-bound form
tion. The lipid molecules in the membrane-bound form are shown in lines.
Fig. 5. Hydrogen-bonding interactions of the speciﬁc regions of CYP17A1 with the lipid molecules (top), and the time evolution of hydrogen bond occupancies of the lipids with the
sidechains (S) and backbones (B) of the residues (bottom) forMem1. CYP17A1 is shown in green ribbon representation. The F–Ghelices, A helix, andβ11′–β12′ sheets are shown in ribbon
representation in purple, yellow, and blue, respectively. Residues and lipid molecules are shown in stick representation. S and B represent the sidechain and backbone of the residue,
respectively.
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the protein within the membrane environment have been suggested
to be closely relevant to determine the well-deﬁned orientations of
CYP17A1 with respect to the membrane plane. The results indicate
that CYP17A1 does not interact with the membrane merely through
the simple nonspeciﬁc contacts, but rather through speciﬁc mem-
brane–enzyme interactions that closely control the pose of the protein
on the surface of the membrane. These hydrogen bonds together with
the hydrophobic interactions are hypothesized to mediate the interac-
tions of the globular domain of CYP17A1 with the membrane and may
further have impact on the catalytic activity of CYP17A1 in the lipid
bilayer.
3.5. Membrane-induced modulation of access tunnels
The active site of CYPs is usually isolated from the surrounding sol-
vent, and buried in the core of the enzymes. The deeply buried active
site points out the question of how molecular species enter the active
site from protein surface through a series of access channels prior to re-
action, a process that is particularly important formembrane-associated
CYPs. Thus, the occurrences of tunnels in CYPs are highly concerned for
its important role in protein engineering and drug design [57].
In our simulations, we have investigated the opening and closing
motions of the substrate access tunnels induced by the interaction of
CYP17A1 with the membrane, particularly for the tunnels facing the
membrane. Multiple protein conformations were chosen to analyze
the relevant features of individual transport tunnels in all membrane
and solution simulations. Five top ranked tunnels identiﬁed throughout
theMD simulations and their time evolution openings are all visualized
in Fig. 6. Then the tunnels of the last 50 nsMD simulationswere charac-
terized by the average-link algorithmbased on the pairwise distances of
the tunnels. The characteristics of these tunnels are summarized in
Table S2.As shown in Fig. 6, the locations of the top ranked ﬁve tunnels are
deﬁned as 2f, S, 2b, 3, and 2fg. The nomenclature for these tunnels is
identiﬁed systematically by Cojocaru et al. [57]. Tunnels 2f, 2b and 2fg
are subclasses of tunnel 2. Tunnel 2f locates between the F–G loop,
Pro-rich loop, and A helix, whereas tunnel 2b locates between the F–G
loop and B–C loop. These pathways are relatively common in other cy-
tochrome P450s [57–59]. However, tunnel 2fg, which has egress
through the F–G loop, is rarely observed in other CYPs and serves as a
newly dominant tunnel. Tunnel 3 locates between the F and G helices.
It is identiﬁed as a potential secondary substrate/product egress route
in MD simulations of P450cam [60]. The solvent tunnel (tunnel S),
which runs between the E, F and I helices and β5 sheet, is proposed as
a route for water to enter and leave the active site [57].
In the ﬁve membrane simulations, the main opening movement
which is necessary for the substrate binding and product release is
commonly associated with the F–G region. Tunnels 2f, 2fg, and 2b
were observed to open to various degrees and penetrate into the lipid
bilayer with the protein hydrophobic residues in the F–G loop
interacting with the lipids. The slight movement of the G helix toward
the lipids was suggested to mediate thewider opening of tunnel 2f dur-
ing the last 50 ns of themembrane simulations. Remarkably, an alterna-
tive pathway through the tunnel 2fg was signiﬁcantly more open in the
membrane simulations. It is suggested that the interaction of CYP17A1
with themembranewould favor the opening of tunnel 2fg by extending
the F–G loop into the hydrophobic interior. By comparing the residues
in the membrane-bound form and in the solution form, the opening of
tunnel 2fg is inferred to be promoted by the opening of the internal
aromatic gate formed by Trp220 and Phe224 in the membrane-bound
form, whereas the entrance of this tunnel in the solution formwas par-
tially locked by the steric hindrance of the side chains of these residues
(Fig. 4). Moreover, tunnels 2f and 2fg were observed to open wider
in the membrane-bound form systems with ~60° tilt angles than in
the systems with ~40° tilt angles except for system Mem2. The more
Fig. 6.Membrane-induced rearrangement of the access tunnels. Five top ranked collective pathways identiﬁed throughout the MD simulations are all depicted in one frame as pathway
surfaces for themembrane-bound systemswith (A) ~40° tilt angles and (B) ~60° tilt angles. Pathways following the ranking order are shown as red, yellow, pink, orange, and blue surfaces,
respectively. (C) Time evolution between the opening and closing of different pathways during the membrane-bound and solution simulations. The color map ranges from very narrow
(orange) to wide (green) bottlenecks.
2019Y.-L. Cui et al. / Biochimica et Biophysica Acta 1848 (2015) 2013–2021opening of 2fg was also correlatedwith the opening of tunnel 2b, which
was facilitated by the extended motion of the F–G loop away from the
B–C loop.
Different from these tunnels which are facing the membrane, the
opening and closing motions of tunnel 3 and tunnel S seemed to be in-
dependent of the conformations of the F–G loop, aswell as the presence
of the membrane. These two tunnels were intermittently opening
throughout the membrane-bound and solution simulations. Thus, it is
inferred that the rearrangement of the F–G region in the membrane-
bound simulations is directly relevant to the opening and closing of
the access tunnels facing the lipid layer, and may further inﬂuence the
recruitment of lipophilic substrates from the membrane into the active
site.
It should be noted that although these tunnels are signiﬁcant for the
recruitment of lipophilic substrates, the complete process and the
ultimate open conﬁguration of these tunnels have not been captured.
The simulations are performed with the substrate in the active site of
the enzyme. In this form, the complex structures are usually in closed
conformation. The radii of the observed tunnels are still too small for
some large substrates, indicating that further changes are needed to
accommodate the substrates. The present study provides the main
potential pathways in the closed form of the protein.4. Conclusion
In conclusion, our present study indicates the value in modeling and
simulating CYPs in their native, membrane-bound cellular environ-
ment. An important caveat for the investigation of CYPs is the fact that
most studies appear to provide simulations in their solution formwith-
out taking into account the interaction of the enzyme with membrane,
which could affect structural and dynamical characteristics of the
enzyme. In the present study, we have constructed the structural
models for the membrane-bound state of CYP17A1. The simulations re-
sulted in convergent models of spontaneous binding and insertion of
the globular domain of CYP17A1, characterized by the depths of inser-
tion and orientations of the globular domain on the membrane surface.
Remarkably, two predominant orientations captured in the ﬁve
membrane-bound simulations provide a good consistence with the ex-
periment data, which further veriﬁes the validity of our structural
models. The detailed hydrogen-bonding and hydrophobic interactions
provide an important suggestion that the CYP17A1 may interact with
the membrane through speciﬁc membrane–enzyme interactions that
stabilize the binding mode of the protein with the membrane, rather
than simply through the adsorption to the surface. Furthermore, the
membrane binding of CYP17A1 has signiﬁcant structural and dynamical
2020 Y.-L. Cui et al. / Biochimica et Biophysica Acta 1848 (2015) 2013–2021impacts on its globular domain at themembrane interface, that the pri-
marily conformational changes of speciﬁc regions may play an impor-
tant role in the opening and closing of different tunnels for efﬁcient
recruitment of lipophilic substrates from themembrane to the enzyme's
buried active site. The dynamics of the aromatic residues are suggested
to regulate tunnel opening motions. The opening of 2fg was facilitated
by the opening of the internal aromatic gate formed by Trp220 and
Phe224. Such structural characteristics are associated with the fact
that the recruitment and binding of substrates are directly through the
membrane into the active site of the enzyme. In summary, our present
work provides detailed atomistic insights into the effects of the pres-
ence of the membrane on the structural and dynamical properties of
CYP17A1. The knowledge of the membrane binding characteristics
could guide future experimental and computational works on
membrane-bound CYPs so that various investigations of CYPs in their
native, membrane-bound cellular environment may be achieved.
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